Evidence map›Paper›PMID 29748775›Full record

ArticleJournal of thrombosis and thrombolysis2018

Congenital hypodysfibrinogenemia associated with a novel deletion of three residues (γAla289_Asp291del) in fibrinogen.

Liqing Zhu, Misheng Zhao, Mingshan Wang, Zhefeng Lou, Xiaoli Chen, Liangliang Pan, Dandan Yu, Wenli Xia, Han Wang, Bin Zhou and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of thrombosis and thrombolysis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Liqing ZhuDepartment of Clinical Laboratory, The First Hospital of Wenzhou Medical University, Nanbaixiang, Ouhai District, Wenzhou, 325000, China.
Misheng ZhaoDepartment of Clinical Laboratory, Wenzhou People's Hospital, Lucheng District, Wenzhou, 325000, China.
Mingshan WangDepartment of Clinical Laboratory, The First Hospital of Wenzhou Medical University, Nanbaixiang, Ouhai District, Wenzhou, 325000, China.
Zhefeng LouSchool of Laboratory Medicine and Life Science, Wenzhou Medical University, Nanbaixiang, Ouhai District, Wenzhou, 325000, China.
Xiaoli ChenDepartment of Clinical Laboratory, The First Hospital of Wenzhou Medical University, Nanbaixiang, Ouhai District, Wenzhou, 325000, China.
Liangliang PanSchool of Laboratory Medicine and Life Science, Wenzhou Medical University, Nanbaixiang, Ouhai District, Wenzhou, 325000, China.
Dandan YuDepartment of Clinical Laboratory, The First Hospital of Wenzhou Medical University, Nanbaixiang, Ouhai District, Wenzhou, 325000, China.
Wenli XiaDepartment of Clinical Laboratory, Wenzhou People's Hospital, Lucheng District, Wenzhou, 325000, China.
Han WangDepartment of Clinical Laboratory, Wenzhou People's Hospital, Lucheng District, Wenzhou, 325000, China.
Bin ZhouDepartment of Internal Medicine, The First Hospital of Wenzhou Medical University, Nanbaixiang, Ouhai District, Wenzhou, 325000, China.
Shenmeng GaoDepartment of Internal Medicine, The First Hospital of Wenzhou Medical University, Nanbaixiang, Ouhai District, Wenzhou, 325000, China. gaoshenmeng77@126.com.
Wenzhou Medical University · CNFirst Affiliated Hospital of Wenzhou Medical University · CNWenzhou City People's Hospital · CN

Funding

National Natural Science Foundation of China 81501810National Natural Science Foundation of China 81672087Natural Science Foundation of Zhejiang Province LQ15H200001
6 · The paper itself

Abstract

Hypodysfibrinogenemia is the least frequently reported congenital fibrinogen disorder, characterized by both quantity and quality defects of fibrinogen. In this study, we investigated the molecular basis of hypodysfibrinogenemia in a Chinese family. Functional fibrinogen was measured by Clauss method, and the antigenic fibrinogen was measured by immunoturbidimetry assay. All the exons and exon-intron boundaries of fibrinogen genes (FGA, FGB and FGG) were analysed by direct DNA sequencing. To further evaluate its molecular and functional characterizations, fibrinogen was purified from the plasma of propositus, then SDS-PAGE, fibrin polymerization, clot lysis, and electron microscopy scanning were all performed. The propositus showed a slight decrease of immunologic fibrinogen (1.52 g/L) but dramatically reduced functional fibrinogen (0.3 g/L). DNA sequencing revealed a novel heterozygous CCTTTGATG deletion in the exon 8 of FGG, leading to the deletion of Ala289, Phe290, and Asp291 in fibrinogen γ-chain. The polymerization of the fibrinogen from the propositus was markedly impaired, with prolonged lag period and decreased final turbidity. The fibrinogen clottability showed a reduced fraction of participating clot formation. While the clot lysis showed normal. Scanning electron microscopy revealed that the fibers of the propositus were thicker than normal, with larger pores and curlier meshworks. We conclude that γAla289_Asp291del is responsible for the hypodysfibrinogenemia in this case.

Indexed as

Sequence DeletionAfibrinogenemiaAsian PeopleFamilyFibrinogenHumansPolymerizationSequence Analysis, DNAThrombosisFibrinogenAmino acid deletionFibrin clot formationFibrinogenFibrinolysisFibrin polymerizationHypodysfibrinogenemia

Identifiers

PMID29748775
OpenAlexW2801996866

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.